U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2020
742
Name Type Language
BELANTAMAB MAFODOTIN
INN  
Official Name English
GSK2857916
Code English
BELANTAMAB MAFODOTIN [MI]
Common Name English
BELANTAMAB MAFODOTIN [USAN]
Common Name English
belantamab mafodotin [INN]
Common Name English
GSK-2857916
Code English
Belantamab mafodotin [WHO-DD]
Common Name English
BELANTAMAB MAFODOTIN [JAN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17),(HUMANIZED MONOCLONAL GSK2857914 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL GSK2857914 .KAPPA.-CHAIN, DIMER, TETRATHIOETHER WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-
Systematic Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 17 (B-CELL MATURATION PROTEIN, ANTIGEN CD269))HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN F.GAMMA.1 HEAVY CHAIN (1-451) (HUMANIZED VH (HOMO SAPIENS I
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 590517
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C114299
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
USAN
GH-35
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
CAS
2050232-20-5
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
WIKIPEDIA
Belantamab mafodotin
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
INN
10754
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
FDA UNII
DB1041CXDG
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
LACTMED
Belantamab Mafodotin
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
RXCUI
2387834
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
MERCK INDEX
m12230
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
CAS
1629760-04-8
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
NO STRUCTURE GIVEN
DAILYMED
DB1041CXDG
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
SMS_ID
100000181695
Created by admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966